Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

2(40.0%)

5Total

N/A(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06262776Not ApplicableRecruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Role: lead

NCT07430475Completed

Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study

Role: collaborator

NCT06260618Not ApplicableRecruiting

Effect of Chitodex Gel in Tympanoplasty Surgery

Role: lead

NCT04769518Not ApplicableTerminated

Advanced Recovery Room Care II - Improved Recovery After Surgery

Role: collaborator

NCT04453852Phase 1Completed

Monovalent Recombinant COVID19 Vaccine

Role: collaborator

NCT04524429Unknown

Quality of Life After Bariatric Surgery

Role: collaborator

NCT03066986Phase 1Unknown

Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)

Role: lead

NCT04431583Completed

Transition of Single Surgeon Bariatric Service to an Interdisciplinary Multiple Surgeon Model

Role: collaborator

All 8 trials loaded